First Trust Advisors
KROS icon

First Trust Advisors’s Keros Therapeutics KROS Stock Holding History

First Trust Advisors’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,130
Closed -$1.4M – 2609
2024
Q3 		$1.4M Buy
24,130
+14,006
+138% +$813K ﹤0.01% 1912
2024
Q2 		$463K Buy
10,124
+1,876
+23% +$85.7K ﹤0.01% 2143
2024
Q1 		$546K Buy
+8,248
New +$546K ﹤0.01% 2124